This break-even analysis covers revenue, fixed costs, variable expenses, contribution margin, timing, and downside cases for a US patient-specific implant manufacturer The base planning case uses $1289M Year 1 revenue, $1615k fixed monthly costs, and a 793% contribution margin It does not guarantee sales, reimbursement, legal clearance, or clinical outcomes